Monkeypox eradication in the U.S. is unlikely in the near future, as experts anticipate low-level transmission will continue indefinitely, according to a CDC technical brief published Sept. 29.
BlueBird Bio’s two drugs for rare diseases that each cost about $3 million — the most expensive drugs on the market — are fairly priced, the chief operating officer at a rival drugmaker told Bloomberg in an Oct. 5 report.
Chicago-based CommonSpirit, the second-largest nonprofit hospital chain in the U.S., has confirmed a cybersecurity incident has disrupted medical services, IT systems and EHR systems at its facilities across the country.